Blocking single gene aids spinal cord injuries: researchers

April 22, 2010

Shutting off the function of a single gene in the body could someday help victims of spinal cord injuries avoid paralysis, researchers announced Wednesday.

The discovery potentially opens the door to new treatments and improved long-term recovery from such injuries which often result in life-long damage and sky-high rehabilitation and hospitalization costs.

Researchers said they administered a drug to lab mice and rats that shut off a specific gene which kicks in after a spinal cord injury.

The gene, Abcc8, is part of the body's protective reaction in the event of spinal cord damage.

The gene activates the Sulfonylurea receptor-1 (Sur1) protein, which can paradoxically end up inflicting more damage to the spinal cord's own cells, according to lead researcher Marc Simard of the University of Maryland School of Medicine.

Sur1 uses sodium to protect cells from an excess of calcium that floods a severely injured area, but the defense mechanism sends the into overdrive, allowing an unchecked influx of sodium into the cells, which can lead to cell death.

"By shutting down the Abcc8 gene that encodes the Sur1 protein the researchers were able to halt the self-destructive process and improve long-term recovery in spinal cord injured mice," according to a summary of the report published in Science Translational Medicine.

Simard's team studied spinal cord tissue from humans, mice and rats and found that the same process of cell death and destruction brought on by Sur1 was present in each of the species.

Shutting the gene off allowed researchers to preserve in the mice, with lesions between one-third and one-fourth the size of those in the control animals.

Researchers neutralized Abcc8 in mice using oligodeoxynucleotide, a short, single strand of DNA which clings to and temporarily blocks their activation.

About half of people with become paraplegic.

A sharp blow on the spine can fracture or dislocate the vertebrae, which in turn can crush and destroy the branches of neurons in the spinal cord which send signals to and from the brain.

Simard's research, which would still need years of clinical trials before a drug using the Abcc8 neutralizer can be sold publicly, lead to treatment which significantly reduces the destruction of nerve tissue in the aftermath of a injury.

Related Stories

Recommended for you

Gut hormone and brown fat interact to tell the brain it's time to stop eating

November 15, 2018
Researchers from Germany and Finland have shown that so-called "brown fat" interacts with the gut hormone secretin in mice to relay nutritional signals about fullness to the brain during a meal. The study, appearing November ...

Brain, muscle cells found lurking in kidney organoids grown in lab

November 15, 2018
Scientists hoping to develop better treatments for kidney disease have turned their attention to growing clusters of kidney cells in the lab. One day, so-called organoids—grown from human stem cells—may help repair damaged ...

Researchers discover important connection between cells in the liver

November 15, 2018
University of Minnesota Medical School researchers have made a discovery which could lead to a new way of thinking about how disease pathogenesis in the liver is regulated, which is important for understanding the condition ...

How the Tasmanian devil inspired researchers to create 'safe cell' therapies

November 15, 2018
A contagious facial cancer that has ravaged Tasmanian devils in southern Australia isn't the first place one would look to find the key to advancing cell therapies in humans.

Precision neuroengineering enables reproduction of complex brain-like functions in vitro

November 14, 2018
One of the most important and surprising traits of the brain is its ability to dynamically reconfigure the connections to process and respond properly to stimuli. Researchers from Tohoku University (Sendai, Japan) and the ...

Gene mutation found to cause macrocephaly and intellectual deficits

November 13, 2018
The absence of one copy of a single gene in the brain causes a rare, as-yet-unnamed neurological disorder, according to new research that builds on decades of work by a University at Buffalo biochemist and his colleagues.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.